Zhongxiu “Sue” Hu, M.S., is a Biomedical Engineering PhD candidate at Columbia University developing biomarkers for disease progression predictions. She graduated with highest honors in physics and chemistry from the University of North Carolina at Chapel Hill in 2022 and earned an M.S. in Medical Physics from Columbia University in 2024. Hu’s earliest work uncovered the influence of lipid membranes on protein-driven liquid–liquid phase separation. At Columbia University, she creates deep-learning models that transform multiparametric abdominal MRI into individualized biomarkers. She has developed mathematical models that measure kidney and cyst growth and forecast Tolvaptan therapy response in autosomal dominant polycystic disease (ADPKD). Hu’s long-term goal is to fuse physics-informed AI with longitudinal imaging to deliver earlier diagnosis and individualized therapy to patients with chronic disease.